PDPK1 and hepatocellular carcinoma: Increased PDPK1 expression promotes gemcitabine resistance in pancreatic adenocarcinoma cells (Li et al., 2018) and radiation resistance in hepatocellular carcinoma (Bamodu et al., 2020).